The conference‘s goal - as the first of its kind in Europe - is to bring together all those involved in the research, development and use of X-Rays in a wide range of applications. CARAT serves as a unique platform for research groups, manufacturers and system providers as well as users who want to inform themselves about the current state of X-Ray technology, the most important challenges and in particular the future developments and possibilities.
In exciting lectures and especially in the interactive formats, the mutual wishes and expectations are discussed and thus the realization of visionary approaches are promoted.
The conference has been initiated by Siemens Healthineers and is embedded in the congress and partnering ”MedTech Summit”, which will take place in conjunction with the new MedtecLIVE trade fair.
Members of university and non-university scientific institutions and clinics have the opportunity to present posters about their research projects to an international expert audience and get in contact with potential cooperation partners.
First authors of accepted posters can register for the conference and the parallel MedTech Summit congress at the student price of 50 €. The exhibition of the scientific poster itself is free of charge.
The poster exhibition is open during conference hours from 8:30 am to 5:00 p.m.
For application please refer to the Information and Registration Documents:
At the parallel MedTech Summit 2019, medical technology will meet innovation and trailblazing technologies. Scientific and market-specific presentations will deliver insights into cross-technology approaches, industry trends and processes.
The agenda will feature interactive and interdisciplinary items to help you generate new solutions.
The established B2B Partnering is the place to network and exchange ideas with all participants of CARAT, the MedTech Summit as well as with exhibitors and attendees of the MedtecLIVE. A matchmaking tool provides a platform to search for potential partners based on profiles and interests.